Electrochemotherapy as a First Line Treatment in Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx PDL-1 Negative and/or with Evident Contraindication to Immunotherapy: A Randomized Multicenter Controlled Trial.
Cancers (Basel)
; 13(9)2021 May 04.
Article
in En
| MEDLINE
| ID: mdl-34064511
Full text:
1
Collection:
01-internacional
Health context:
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Cancers (Basel)
Year:
2021
Document type:
Article